Curanex Pharmaceuticals Inc (CURX) AI Dilution Summary

The company reported cash of $2,938,463 at 2026-06-30 against estimated monthly burn of $360,037, funded to date through its August 2025 initial public offering and the related over-allotment exercise rather than through any facility stated in the facts block.